The study looked at 83 patients having a posterior SI joint fusion with the LinQ implant, according to a March 20 news release. The study found statistically significant improvement in visual analog scale sores. The mean improvement was 43.3 at 12 months compared to baseline.
The LinQ implant also showed a strong safety profile with five adverse events and no implant-related adverse events in the patients.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
